Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,858,445
-$878,578 QoQ
Shares Held
265,199
-25.2% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
3.39%
of 13F equity value
Holder Rank
#82
of 257 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACUTA CAPITAL PARTNERS, LLC holds $139,270,289 across 21 Biotechnology names. ERAS ranks #9 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
82,796 | $27,719,272 | |
| 2 | WHWK |
Whitehawk Therapeutics, Inc.
|
4,685,912 | $21,461,476 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
390,949 | $12,221,065 | |
| 4 | STRO |
Sutro Biopharma, Inc.
|
270,251 | $8,972,333 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
218,694 | $7,597,429 | |
| 6 | FDMT |
4D Molecular Therapeutics, Inc.
|
507,801 | $6,753,753 | |
| 7 | DRUG |
Bright Minds Biosciences Inc.
|
92,745 | $6,510,699 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
532,481 | $5,228,963 |
All Filings in ERAS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,858,445 | 265,199 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,737,023 | 354,575 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||